Evolent Health, Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 25.67M96.88M254.19M434.95M627.06M687.12M924.64M907.96M1,352.01M1,963.90M2,554.74M
Cost of Revenue 30.02M57.40M155.18M269.35M327.82M513.03M696.58M657.55M1,035.43M1,503.43M2,187.39M
Gross Profit -4.35M39.48M99.01M165.60M299.24M174.09M228.06M250.41M316.58M460.47M367.35M
Operating items
Depreciation & Amortization - Total 0.80M1.20M2.60M9.20M17.30M23.30M28.30M30.60M32.00M32.40M30.30M
Selling, General & Administrative 15.60M75.29M160.69M205.67M235.42M236.45M210.41M219.50M269.27M358.11M263.05M
Other Operating Expenses 0.00M63.36M0.00M0.17M0.11M9.60M-0.70M700.27M1,047.10M1,644.60M-18.92M
Operating Expenses 46.83M139.85M491.61M507.79M674.54M996.01M1,187.49M950.37M1,348.37M2,035.11M2,595.23M
Operating Income -21.16M-42.97M-237.42M-72.84M-47.48M-308.88M-262.85M-42.41M3.64M-71.21M-40.48M
EBIT -21.16M-25.25M-42.97M-237.42M-72.84M-47.48M-308.88M-262.85M-42.41M3.64M-71.21M-40.48M
Non-operating items
Non Operating Investment Income 414.13M
Interest & Investment Income 0.29M0.97M1.66M3.44M3.41M2.63M0.41M1.37M5.26M5.54M
Other Non Operating Income -0.12M-21.34M-10.19M-21.01M0.24M
Non Operating Income -0.12M-0.15M0.06M-0.54M0.24M
Net income details
EBT 20.03M-25.25M343.29M-237.53M-76.40M-54.15M-329.99M-330.54M-29.80M-62.08M-202.41M-63.04M
Tax Provisions 0.01M23.50M-10.76M-6.64M0.04M-22.80M-2.40M0.50M-43.40M-89.40M-1.41M
Profit After Tax 20.02M-25.25M332.49M-226.78M-69.77M-54.19M-307.19M-334.25M-37.60M-19.16M-113.04M-61.62M
Equity Income -4.24M-25.25M-28.16M-0.84M-1.80M-4.74M-9.50M10.04M13.20M4.60M1.30M-3.44M
Income from Non-Controlling Interests -12.68M-67.04M-9.10M-1.53M-3.61M
Income from Continuing Operations 20.02M-25.25M319.79M-226.78M-69.77M-54.19M-307.19M-328.14M-30.30M-18.68M-113.00M-61.62M
Consolidated Net Income 20.02M-25.25M319.79M-226.78M-69.77M-54.19M1.61M-6.07M-7.32M-0.46M-113.00M-61.62M
Income towards Parent Company 20.02M-25.25M319.79M-226.78M-69.77M-54.19M1.61M-6.07M-7.32M-0.46M-113.00M-61.62M
Preferred Dividend Payments 5.14M2.18M29.22M31.83M
Net Income towards Common Stockholders 2.96M-31.14M330.31M-159.74M-60.66M-54.19M-301.97M-334.25M-37.60M-19.16M-142.26M-93.45M
Additional items
EPS (Basic) 2.51-13.4613.14-3.55-0.94-0.68-3.73-3.94-0.44-0.20-1.28-0.81
EPS (Weighted Average and Diluted) 0.99-13.466.93-3.55-0.94-3.73-3.94-0.44-0.20-1.28-0.81
Shares Outstanding (Weighted Average) 59.00M67.92M77.34M82.23M84.61M85.78M89.41M101.19M114.96M116.56M
Shares Outstanding (Diluted Average) 2.99M2.31M46.14M45.03M64.35M82.36M84.93M86.07M93.70M111.25M114.68M
EBITDA -20.36M-25.25M-41.77M-226.78M-69.77M-54.37M-305.63M-334.29M-37.69M-19.98M-142.34M-93.95M
Interest Expenses 0.25M3.64M5.48M14.55M28.32M25.43M15.57M54.20M24.72M
Tax Rate 0.04%6.85%4.53%8.69%6.91%0.73%69.91%44.17%2.24%